SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of Commencement of a Class Ac...
November 14 2016 - 2:22PM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All persons or entities who purchased or otherwise
acquired securities of Spectrum Pharmaceuticals, Inc. (“Spectrum
Pharmaceuticals”) (NASDAQGS:SPPI) between December 16, 2015 and September 16,
2016.
You are hereby notified that a securities class action
lawsuit has been commenced in the United States District Court for
the District of Nevada. If you purchased or otherwise acquired
Spectrum Pharmaceuticals between December 16, 2015 and September
16, 2016, your rights may be affected by this action. To get more
information go to:
http://www.zlk.com/pslra/spectrum-pharmaceuticals-inc
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
The Complaint alleges that throughout the Class Period
defendants made false and/or misleading statements and/or failed to
disclose that: (1) the Food and Drug Administration (the "FDA")
questioned whether the data from the 611 and 612 Studies were
clinically significant; (2) the FDA informed defendants in December
2012 not to submit the New Drug Application based on data from the
611 and 612 Studies; and (3) accordingly, defendants' public
statements concerning the Company's business, operations and
prospects were materially false and misleading at all relevant
times.
If you suffered a loss in Spectrum Pharmaceuticals
you have until November 21,
2016 to request that the Court appoint you as lead
plaintiff. Your ability to share in any recovery doesn’t require
that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation involving financial
fraud, and have recovered hundreds of millions of dollars for
aggrieved shareholders. Attorney advertising. Prior results do not
guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161114006394/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq., 212-363-7500Toll
Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2023 to Apr 2024